Lung Fibrosis Pulmonary Function Study
This study observes how different treatments affect lung function in people with lung fibrosis, measuring changes in forced vital capacity (FVC), forced expiratory volume in the first second (FEV1), and the ratio of FEV1 to FVC.
Routine medical care
+ Pulmonary rehabilitation
Fibrosis+4
+ Lung Diseases
+ Pathologic Processes
Treatment Study
Summary
Study start date: December 1, 2024
Actual date on which the first participant was enrolled.The study is designed to explore the effects of different treatments on lung function in patients diagnosed with pulmonary fibrosis, a condition that causes scarring and stiffness in the lungs. It targets both men and women aged between 35 and 55 years old. This research is important as it aims to identify effective treatments that could improve breathing and overall lung health for individuals suffering from this challenging condition. Participants in the study will be randomly assigned to different groups to receive various interventions aimed at treating pulmonary fibrosis. The study will monitor and evaluate lung function improvements throughout the trial. By comparing results across different treatment groups, researchers hope to find the best strategies for managing and potentially improving the quality of life for patients with lung fibrosis.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.60 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 35 to 55 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Group II
Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location